Complementary and Alternative Medicine: Fair, Balanced, and to the Point
About this web log
This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.
About the author
John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.
Top topics on The CAM Report
*Animal-assisted Therapy
*Birth Defects
*Arsenic in modern medicine
*Mindfulness and cognitive behavioral therapy
*TENS/FNS/VNS
The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.
Support this site
If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.
Researchers from the Mayo Clinic in Minnesota and Arizona collaborated to review the risks of herbal:drug interactions.
The abstract is a bit skimpy on details, but the American Pharmaceutical Association has a nice summary, which will be summarized further here. (more…)
Professor Ernst and colleagues from the Universities of Exeter and Plymouth in the UK report significant benefit in symptom control and physiologic outcomes from hawthorn extract when included in the treatment for chronic heart failure. (more…)
It seems to improve self-esteem but not cognition (eg, perception, memory, judgment, and reasoning) or literacy, according to a recent study of 70 dyslexic children aged 6 to 13 years.
In 2003, Professor Edzard Ernst writing on the Cochrane Collaboration website concluded, “Compared with placebo, kava extract is an effective symptomatic treatment for anxiety although, at present, the size of the effect seems small.” (more…)
In people with advanced congestive heart failure (CHF) WS 1442 (aka, hawthorn) does not change the incidence of death due to progressive heart failure, fatal heart attack, or non-fatal heart attack. It also doesn’t affect the chances of being put in the hospital because of heart failure. (more…)